nodes	percent_of_prediction	percent_of_DWPC	metapath
Moclobemide—MAOA—bipolar disorder	0.826	1	CbGaD
Moclobemide—MAOA—locus ceruleus—bipolar disorder	0.0148	0.216	CbGeAlD
Moclobemide—MAOB—Biogenic amines are oxidatively deaminated to aldehydes by MAOA and MAOB—MAOA—bipolar disorder	0.011	0.114	CbGpPWpGaD
Moclobemide—MAOA—Enzymatic degradation of Dopamine by monoamine oxidase—COMT—bipolar disorder	0.00696	0.0723	CbGpPWpGaD
Moclobemide—CYP2C19—urine—bipolar disorder	0.00654	0.0958	CbGeAlD
Moclobemide—MAOB—Amine Oxidase reactions—MAOA—bipolar disorder	0.00632	0.0657	CbGpPWpGaD
Moclobemide—MAOA—Clearance of dopamine—SLC6A3—bipolar disorder	0.00592	0.0615	CbGpPWpGaD
Moclobemide—CYP1A2—urine—bipolar disorder	0.00534	0.0782	CbGeAlD
Moclobemide—CYP2C9—urine—bipolar disorder	0.00507	0.0742	CbGeAlD
Moclobemide—MAOA—Clearance of dopamine—COMT—bipolar disorder	0.00503	0.0523	CbGpPWpGaD
Moclobemide—MAOB—blood plasma—bipolar disorder	0.00392	0.0573	CbGeAlD
Moclobemide—MAOA—Norepinephrine Neurotransmitter Release Cycle—CPLX1—bipolar disorder	0.00387	0.0402	CbGpPWpGaD
Moclobemide—CYP2D6—urine—bipolar disorder	0.00381	0.0557	CbGeAlD
Moclobemide—CYP2C19—blood plasma—bipolar disorder	0.00341	0.05	CbGeAlD
Moclobemide—MAOA—blood plasma—bipolar disorder	0.00334	0.0489	CbGeAlD
Moclobemide—MAOA—Serotonin Transporter Activity—TPH2—bipolar disorder	0.00294	0.0305	CbGpPWpGaD
Moclobemide—CYP1A2—blood plasma—bipolar disorder	0.00279	0.0408	CbGeAlD
Moclobemide—MAOA—Neurotransmitter Clearance In The Synaptic Cleft—SLC6A3—bipolar disorder	0.0027	0.0281	CbGpPWpGaD
Moclobemide—CYP2C9—blood plasma—bipolar disorder	0.00265	0.0387	CbGeAlD
Moclobemide—MAOB—Dopamine metabolism—COMT—bipolar disorder	0.00248	0.0258	CbGpPWpGaD
Moclobemide—MAOA—Biogenic Amine Synthesis—GAD1—bipolar disorder	0.00246	0.0256	CbGpPWpGaD
Moclobemide—MAOB—Dopamine metabolism—MAOA—bipolar disorder	0.00246	0.0256	CbGpPWpGaD
Moclobemide—MAOA—Serotonin Transporter Activity—SLC6A4—bipolar disorder	0.00235	0.0244	CbGpPWpGaD
Moclobemide—MAOA—Neurotransmitter Clearance In The Synaptic Cleft—COMT—bipolar disorder	0.0023	0.0239	CbGpPWpGaD
Moclobemide—MAOB—adrenal cortex—bipolar disorder	0.00199	0.0291	CbGeAlD
Moclobemide—CYP2D6—blood plasma—bipolar disorder	0.00199	0.0291	CbGeAlD
Moclobemide—MAOA—Neurotransmitter Release Cycle—CPLX1—bipolar disorder	0.00196	0.0204	CbGpPWpGaD
Moclobemide—MAOA—adrenal cortex—bipolar disorder	0.0017	0.0248	CbGeAlD
Moclobemide—MAOA—Norepinephrine Neurotransmitter Release Cycle—SNAP25—bipolar disorder	0.00158	0.0165	CbGpPWpGaD
Moclobemide—MAOA—Dopamine metabolism—COMT—bipolar disorder	0.00156	0.0162	CbGpPWpGaD
Moclobemide—MAOB—Alpha-synuclein signaling—SLC6A3—bipolar disorder	0.00146	0.0151	CbGpPWpGaD
Moclobemide—MAOA—Biogenic Amine Synthesis—COMT—bipolar disorder	0.00139	0.0144	CbGpPWpGaD
Moclobemide—MAOA—Melatonin metabolism and effects—CLOCK—bipolar disorder	0.00139	0.0144	CbGpPWpGaD
Moclobemide—MAOB—thyroid gland—bipolar disorder	0.00139	0.0203	CbGeAlD
Moclobemide—Minaprine—MAOA—bipolar disorder	0.00132	0.138	CrCbGaD
Moclobemide—Minaprine—DRD1—bipolar disorder	0.0012	0.126	CrCbGaD
Moclobemide—MAOA—thyroid gland—bipolar disorder	0.00118	0.0173	CbGeAlD
Moclobemide—MAOB—nervous system—bipolar disorder	0.00117	0.0171	CbGeAlD
Moclobemide—Haloperidol—GRIN2B—bipolar disorder	0.00114	0.119	CrCbGaD
Moclobemide—MAOB—cerebellum—bipolar disorder	0.0011	0.016	CbGeAlD
Moclobemide—MAOA—Neurotransmitter Release Cycle—GAD1—bipolar disorder	0.00108	0.0112	CbGpPWpGaD
Moclobemide—Minaprine—HTR2C—bipolar disorder	0.00102	0.107	CrCbGaD
Moclobemide—MAOA—nervous system—bipolar disorder	0.000994	0.0145	CbGeAlD
Moclobemide—CYP1A2—thyroid gland—bipolar disorder	0.000986	0.0144	CbGeAlD
Moclobemide—MAOA—SIDS Susceptibility Pathways—POU3F2—bipolar disorder	0.000951	0.00988	CbGpPWpGaD
Moclobemide—MAOA—cerebellum—bipolar disorder	0.000935	0.0137	CbGeAlD
Moclobemide—MAOB—brain—bipolar disorder	0.000891	0.013	CbGeAlD
Moclobemide—MAOA—Serotonin Transporter Activity—IL1B—bipolar disorder	0.000853	0.00887	CbGpPWpGaD
Moclobemide—Minaprine—SLC6A4—bipolar disorder	0.000848	0.089	CrCbGaD
Moclobemide—Minaprine—DRD2—bipolar disorder	0.000843	0.0885	CrCbGaD
Moclobemide—MAOA—Neurotransmitter Release Cycle—SNAP25—bipolar disorder	0.000804	0.00835	CbGpPWpGaD
Moclobemide—MAOA—brain—bipolar disorder	0.00076	0.0111	CbGeAlD
Moclobemide—CYP1A2—Methylation—COMT—bipolar disorder	0.000708	0.00736	CbGpPWpGaD
Moclobemide—Haloperidol—DRD4—bipolar disorder	0.000668	0.0701	CrCbGaD
Moclobemide—CYP2C19—Melatonin metabolism and effects—CLOCK—bipolar disorder	0.000657	0.00682	CbGpPWpGaD
Moclobemide—Minaprine—HTR2A—bipolar disorder	0.000652	0.0684	CrCbGaD
Moclobemide—CYP2D6—Melatonin metabolism and effects—CLOCK—bipolar disorder	0.000604	0.00628	CbGpPWpGaD
Moclobemide—CYP2D6—nervous system—bipolar disorder	0.000591	0.00865	CbGeAlD
Moclobemide—MAOB—Phase 1 - Functionalization of compounds—MAOA—bipolar disorder	0.000587	0.0061	CbGpPWpGaD
Moclobemide—Haloperidol—DRD3—bipolar disorder	0.000576	0.0605	CrCbGaD
Moclobemide—Haloperidol—DRD1—bipolar disorder	0.000566	0.0594	CrCbGaD
Moclobemide—MAOA—Transmission across Chemical Synapses—CPLX1—bipolar disorder	0.000563	0.00586	CbGpPWpGaD
Moclobemide—CYP2D6—cerebellum—bipolar disorder	0.000556	0.00814	CbGeAlD
Moclobemide—MAOA—Melatonin metabolism and effects—GSK3B—bipolar disorder	0.000534	0.00555	CbGpPWpGaD
Moclobemide—CYP1A2—Melatonin metabolism and effects—CLOCK—bipolar disorder	0.000512	0.00532	CbGpPWpGaD
Moclobemide—CYP2D6—brain—bipolar disorder	0.000452	0.00661	CbGeAlD
Moclobemide—CYP1A2—Estrogen metabolism—COMT—bipolar disorder	0.000442	0.0046	CbGpPWpGaD
Moclobemide—MAOA—Neuronal System—CPLX1—bipolar disorder	0.000432	0.00449	CbGpPWpGaD
Moclobemide—Haloperidol—DRD2—bipolar disorder	0.000399	0.0419	CrCbGaD
Moclobemide—MAOA—SIDS Susceptibility Pathways—GRIN1—bipolar disorder	0.000386	0.00402	CbGpPWpGaD
Moclobemide—CYP2C19—Melatonin metabolism and effects—MAOA—bipolar disorder	0.000385	0.004	CbGpPWpGaD
Moclobemide—MAOB—Phase 1 - Functionalization of compounds—POMC—bipolar disorder	0.000382	0.00397	CbGpPWpGaD
Moclobemide—CYP2D6—Melatonin metabolism and effects—MAOA—bipolar disorder	0.000354	0.00368	CbGpPWpGaD
Moclobemide—MAOA—SIDS Susceptibility Pathways—TPH2—bipolar disorder	0.000352	0.00366	CbGpPWpGaD
Moclobemide—MAOA—SIDS Susceptibility Pathways—TACR1—bipolar disorder	0.000352	0.00366	CbGpPWpGaD
Moclobemide—MAOA—Transmission across Chemical Synapses—GRIK2—bipolar disorder	0.000324	0.00336	CbGpPWpGaD
Moclobemide—MAOA—Transmission across Chemical Synapses—GRIN1—bipolar disorder	0.000317	0.00329	CbGpPWpGaD
Moclobemide—MAOB—Biological oxidations—COMT—bipolar disorder	0.000314	0.00327	CbGpPWpGaD
Moclobemide—MAOB—Biological oxidations—MAOA—bipolar disorder	0.000312	0.00324	CbGpPWpGaD
Moclobemide—MAOA—Transmission across Chemical Synapses—GAD1—bipolar disorder	0.00031	0.00322	CbGpPWpGaD
Moclobemide—Haloperidol—HTR2A—bipolar disorder	0.000308	0.0323	CrCbGaD
Moclobemide—CYP1A2—Melatonin metabolism and effects—MAOA—bipolar disorder	0.0003	0.00312	CbGpPWpGaD
Moclobemide—MAOA—SIDS Susceptibility Pathways—HTR1A—bipolar disorder	0.000291	0.00303	CbGpPWpGaD
Moclobemide—MAOA—Transmission across Chemical Synapses—CACNB2—bipolar disorder	0.000288	0.003	CbGpPWpGaD
Moclobemide—MAOA—SIDS Susceptibility Pathways—TAC1—bipolar disorder	0.000287	0.00298	CbGpPWpGaD
Moclobemide—MAOA—SIDS Susceptibility Pathways—SNAP25—bipolar disorder	0.000281	0.00292	CbGpPWpGaD
Moclobemide—MAOA—SIDS Susceptibility Pathways—GATA3—bipolar disorder	0.000281	0.00292	CbGpPWpGaD
Moclobemide—MAOA—SIDS Susceptibility Pathways—SLC6A4—bipolar disorder	0.000281	0.00292	CbGpPWpGaD
Moclobemide—MAOA—SIDS Susceptibility Pathways—NTRK2—bipolar disorder	0.000274	0.00284	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—IMPA2—bipolar disorder	0.000269	0.00279	CbGpPWpGaD
Moclobemide—CYP2C19—Metapathway biotransformation—AKR1C4—bipolar disorder	0.000256	0.00266	CbGpPWpGaD
Moclobemide—CYP2C19—Melatonin metabolism and effects—GSK3B—bipolar disorder	0.000253	0.00263	CbGpPWpGaD
Moclobemide—MAOA—Neuronal System—GRIK2—bipolar disorder	0.000248	0.00258	CbGpPWpGaD
Moclobemide—MAOA—Neuronal System—GRIN1—bipolar disorder	0.000243	0.00252	CbGpPWpGaD
Moclobemide—MAOA—Phase 1 - Functionalization of compounds—POMC—bipolar disorder	0.00024	0.00249	CbGpPWpGaD
Moclobemide—MAOA—Neuronal System—GAD1—bipolar disorder	0.000238	0.00247	CbGpPWpGaD
Moclobemide—CYP2D6—Metapathway biotransformation—AKR1C4—bipolar disorder	0.000236	0.00245	CbGpPWpGaD
Moclobemide—CYP2C9—Metapathway biotransformation—AKR1C4—bipolar disorder	0.000234	0.00243	CbGpPWpGaD
Moclobemide—CYP2D6—Melatonin metabolism and effects—GSK3B—bipolar disorder	0.000232	0.00242	CbGpPWpGaD
Moclobemide—MAOA—Transmission across Chemical Synapses—SNAP25—bipolar disorder	0.000231	0.0024	CbGpPWpGaD
Moclobemide—MAOA—Neuronal System—CACNB2—bipolar disorder	0.000221	0.0023	CbGpPWpGaD
Moclobemide—MAOA—Transmission across Chemical Synapses—GRIN2B—bipolar disorder	0.000209	0.00217	CbGpPWpGaD
Moclobemide—MAOA—Transmission across Chemical Synapses—SLC6A3—bipolar disorder	0.000206	0.00214	CbGpPWpGaD
Moclobemide—MAOA—SIDS Susceptibility Pathways—BDNF—bipolar disorder	0.000204	0.00212	CbGpPWpGaD
Moclobemide—MAOA—Transmission across Chemical Synapses—ADCY2—bipolar disorder	0.000204	0.00212	CbGpPWpGaD
Moclobemide—MAOB—Biological oxidations—POMC—bipolar disorder	0.000203	0.00211	CbGpPWpGaD
Moclobemide—CYP1A2—Metapathway biotransformation—AKR1C4—bipolar disorder	0.0002	0.00207	CbGpPWpGaD
Moclobemide—MAOA—Biological oxidations—COMT—bipolar disorder	0.000197	0.00205	CbGpPWpGaD
Moclobemide—CYP1A2—Melatonin metabolism and effects—GSK3B—bipolar disorder	0.000197	0.00205	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—IMPA1—bipolar disorder	0.000182	0.00189	CbGpPWpGaD
Moclobemide—MAOA—SIDS Susceptibility Pathways—NR3C1—bipolar disorder	0.00018	0.00188	CbGpPWpGaD
Moclobemide—MAOA—Neuronal System—SNAP25—bipolar disorder	0.000177	0.00184	CbGpPWpGaD
Moclobemide—MAOA—Transmission across Chemical Synapses—COMT—bipolar disorder	0.000175	0.00182	CbGpPWpGaD
Moclobemide—CYP2C19—Phase 1 - Functionalization of compounds—MAOA—bipolar disorder	0.000174	0.00181	CbGpPWpGaD
Moclobemide—MAOA—SIDS Susceptibility Pathways—HTR2A—bipolar disorder	0.000173	0.00179	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—IMPA2—bipolar disorder	0.000169	0.00175	CbGpPWpGaD
Moclobemide—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—bipolar disorder	0.00016	0.00167	CbGpPWpGaD
Moclobemide—MAOA—Neuronal System—GRIN2B—bipolar disorder	0.00016	0.00166	CbGpPWpGaD
Moclobemide—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—bipolar disorder	0.000159	0.00165	CbGpPWpGaD
Moclobemide—MAOA—Neuronal System—SLC6A3—bipolar disorder	0.000157	0.00164	CbGpPWpGaD
Moclobemide—MAOA—Neuronal System—ADCY2—bipolar disorder	0.000156	0.00163	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—NDUFV2—bipolar disorder	0.000154	0.0016	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—AKR1C4—bipolar disorder	0.00015	0.00155	CbGpPWpGaD
Moclobemide—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—bipolar disorder	0.00014	0.00146	CbGpPWpGaD
Moclobemide—CYP1A2—Phase 1 - Functionalization of compounds—MAOA—bipolar disorder	0.000136	0.00141	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—NR1D1—bipolar disorder	0.000134	0.0014	CbGpPWpGaD
Moclobemide—MAOA—Neuronal System—COMT—bipolar disorder	0.000134	0.00139	CbGpPWpGaD
Moclobemide—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—bipolar disorder	0.000129	0.00134	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—NCAN—bipolar disorder	0.000129	0.00134	CbGpPWpGaD
Moclobemide—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—bipolar disorder	0.000128	0.00133	CbGpPWpGaD
Moclobemide—MAOA—Biological oxidations—POMC—bipolar disorder	0.000127	0.00132	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—SLC5A3—bipolar disorder	0.000126	0.00131	CbGpPWpGaD
Moclobemide—CYP1A2—Phase II conjugation—COMT—bipolar disorder	0.000124	0.00129	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—IMPA1—bipolar disorder	0.000114	0.00118	CbGpPWpGaD
Moclobemide—CYP2C19—Phase 1 - Functionalization of compounds—POMC—bipolar disorder	0.000114	0.00118	CbGpPWpGaD
Moclobemide—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—bipolar disorder	0.000109	0.00113	CbGpPWpGaD
Moclobemide—CYP2D6—Phase 1 - Functionalization of compounds—POMC—bipolar disorder	0.000104	0.00109	CbGpPWpGaD
Moclobemide—CYP2C9—Phase 1 - Functionalization of compounds—POMC—bipolar disorder	0.000104	0.00108	CbGpPWpGaD
Moclobemide—MAOA—SIDS Susceptibility Pathways—IL1B—bipolar disorder	0.000102	0.00106	CbGpPWpGaD
Moclobemide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—bipolar disorder	0.0001	0.00104	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C4—bipolar disorder	9.98e-05	0.00104	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—NDUFV2—bipolar disorder	9.69e-05	0.00101	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—AKR1C4—bipolar disorder	9.39e-05	0.000975	CbGpPWpGaD
Moclobemide—CYP2C19—Biological oxidations—COMT—bipolar disorder	9.33e-05	0.00097	CbGpPWpGaD
Moclobemide—CYP2C19—Biological oxidations—MAOA—bipolar disorder	9.27e-05	0.000963	CbGpPWpGaD
Moclobemide—CYP2C19—Metapathway biotransformation—COMT—bipolar disorder	9.21e-05	0.000957	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—CLOCK—bipolar disorder	9.1e-05	0.000946	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C4—bipolar disorder	9.1e-05	0.000945	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—NR1D1—bipolar disorder	8.96e-05	0.000931	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—TPH2—bipolar disorder	8.87e-05	0.000922	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—TSHB—bipolar disorder	8.87e-05	0.000922	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—CACNB2—bipolar disorder	8.87e-05	0.000922	CbGpPWpGaD
Moclobemide—CYP1A2—Phase 1 - Functionalization of compounds—POMC—bipolar disorder	8.85e-05	0.00092	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—DPYD—bipolar disorder	8.73e-05	0.000907	CbGpPWpGaD
Moclobemide—CYP2D6—Biological oxidations—COMT—bipolar disorder	8.58e-05	0.000892	CbGpPWpGaD
Moclobemide—CYP2D6—Biological oxidations—MAOA—bipolar disorder	8.52e-05	0.000886	CbGpPWpGaD
Moclobemide—CYP2C9—Biological oxidations—COMT—bipolar disorder	8.51e-05	0.000884	CbGpPWpGaD
Moclobemide—CYP2D6—Metapathway biotransformation—COMT—bipolar disorder	8.47e-05	0.00088	CbGpPWpGaD
Moclobemide—CYP2C9—Biological oxidations—MAOA—bipolar disorder	8.45e-05	0.000878	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—NR1D1—bipolar disorder	8.43e-05	0.000876	CbGpPWpGaD
Moclobemide—CYP2C9—Metapathway biotransformation—COMT—bipolar disorder	8.39e-05	0.000872	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—NR1D1—bipolar disorder	8.17e-05	0.000849	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—CACNA1C—bipolar disorder	8.11e-05	0.000843	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—NCAN—bipolar disorder	8.06e-05	0.000838	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—IMPA2—bipolar disorder	7.99e-05	0.00083	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—PIK3C2A—bipolar disorder	7.91e-05	0.000822	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—SLC5A3—bipolar disorder	7.9e-05	0.000821	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C4—bipolar disorder	7.77e-05	0.000808	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—IMPA2—bipolar disorder	7.35e-05	0.000763	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—IMPA2—bipolar disorder	7.28e-05	0.000757	CbGpPWpGaD
Moclobemide—CYP1A2—Biological oxidations—COMT—bipolar disorder	7.27e-05	0.000756	CbGpPWpGaD
Moclobemide—CYP1A2—Biological oxidations—MAOA—bipolar disorder	7.22e-05	0.00075	CbGpPWpGaD
Moclobemide—CYP1A2—Metapathway biotransformation—COMT—bipolar disorder	7.17e-05	0.000745	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—SNAP25—bipolar disorder	7.09e-05	0.000737	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—NR1D1—bipolar disorder	6.98e-05	0.000726	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—ADCY2—bipolar disorder	6.28e-05	0.000652	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—IMPA2—bipolar disorder	6.22e-05	0.000647	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—CLOCK—bipolar disorder	6.07e-05	0.000631	CbGpPWpGaD
Moclobemide—CYP2C19—Biological oxidations—POMC—bipolar disorder	6.03e-05	0.000627	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—CLOCK—bipolar disorder	5.71e-05	0.000594	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—TPH2—bipolar disorder	5.57e-05	0.000578	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—TSHB—bipolar disorder	5.57e-05	0.000578	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—CACNB2—bipolar disorder	5.57e-05	0.000578	CbGpPWpGaD
Moclobemide—CYP2D6—Biological oxidations—POMC—bipolar disorder	5.55e-05	0.000577	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—CLOCK—bipolar disorder	5.53e-05	0.000575	CbGpPWpGaD
Moclobemide—CYP2C9—Biological oxidations—POMC—bipolar disorder	5.5e-05	0.000572	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—DPYD—bipolar disorder	5.48e-05	0.000569	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—IMPA1—bipolar disorder	5.39e-05	0.000561	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—COMT—bipolar disorder	5.37e-05	0.000558	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—MAOA—bipolar disorder	5.34e-05	0.000555	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3C2A—bipolar disorder	5.27e-05	0.000548	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—CACNA1C—bipolar disorder	5.09e-05	0.000529	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—IMPA1—bipolar disorder	4.96e-05	0.000516	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—PIK3C2A—bipolar disorder	4.96e-05	0.000516	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—IMPA1—bipolar disorder	4.92e-05	0.000511	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3C2A—bipolar disorder	4.81e-05	0.0005	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—CLOCK—bipolar disorder	4.73e-05	0.000492	CbGpPWpGaD
Moclobemide—CYP1A2—Biological oxidations—POMC—bipolar disorder	4.7e-05	0.000489	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—NDUFV2—bipolar disorder	4.59e-05	0.000477	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—SNAP25—bipolar disorder	4.45e-05	0.000462	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—AKR1C4—bipolar disorder	4.44e-05	0.000462	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—MTHFR—bipolar disorder	4.34e-05	0.000451	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—NDUFV2—bipolar disorder	4.22e-05	0.000438	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—IMPA1—bipolar disorder	4.2e-05	0.000437	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—NDUFV2—bipolar disorder	4.18e-05	0.000435	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3C2A—bipolar disorder	4.11e-05	0.000427	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—AKR1C4—bipolar disorder	4.09e-05	0.000425	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—AKR1C4—bipolar disorder	4.05e-05	0.000421	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—NR1D1—bipolar disorder	3.99e-05	0.000415	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—ADCY2—bipolar disorder	3.94e-05	0.000409	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—NCAN—bipolar disorder	3.82e-05	0.000397	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—SLC5A3—bipolar disorder	3.74e-05	0.000389	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—NR1D1—bipolar disorder	3.67e-05	0.000381	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—NR1D1—bipolar disorder	3.64e-05	0.000378	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—NDUFV2—bipolar disorder	3.57e-05	0.000371	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—NCAN—bipolar disorder	3.51e-05	0.000365	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—NCAN—bipolar disorder	3.48e-05	0.000362	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—POMC—bipolar disorder	3.47e-05	0.000361	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—AKR1C4—bipolar disorder	3.46e-05	0.00036	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—INS—bipolar disorder	3.45e-05	0.000359	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—SLC5A3—bipolar disorder	3.44e-05	0.000357	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—SLC5A3—bipolar disorder	3.41e-05	0.000354	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—COMT—bipolar disorder	3.37e-05	0.00035	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—NR1D1—bipolar disorder	3.11e-05	0.000323	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—NCAN—bipolar disorder	2.97e-05	0.000309	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—SLC5A3—bipolar disorder	2.91e-05	0.000303	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—MTHFR—bipolar disorder	2.73e-05	0.000283	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—CLOCK—bipolar disorder	2.7e-05	0.000281	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—TSHB—bipolar disorder	2.63e-05	0.000274	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—CACNB2—bipolar disorder	2.63e-05	0.000274	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—TPH2—bipolar disorder	2.63e-05	0.000274	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—DPYD—bipolar disorder	2.59e-05	0.000269	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—CLOCK—bipolar disorder	2.49e-05	0.000258	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—CLOCK—bipolar disorder	2.46e-05	0.000256	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—TSHB—bipolar disorder	2.42e-05	0.000252	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—CACNB2—bipolar disorder	2.42e-05	0.000252	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—TPH2—bipolar disorder	2.42e-05	0.000252	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—CACNA1C—bipolar disorder	2.41e-05	0.00025	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—TSHB—bipolar disorder	2.4e-05	0.00025	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—TPH2—bipolar disorder	2.4e-05	0.00025	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—CACNB2—bipolar disorder	2.4e-05	0.00025	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—DPYD—bipolar disorder	2.38e-05	0.000248	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—DPYD—bipolar disorder	2.36e-05	0.000246	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—PIK3C2A—bipolar disorder	2.35e-05	0.000244	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—POMC—bipolar disorder	2.32e-05	0.000241	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—CACNA1C—bipolar disorder	2.22e-05	0.00023	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—CACNA1C—bipolar disorder	2.2e-05	0.000228	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—POMC—bipolar disorder	2.18e-05	0.000227	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—INS—bipolar disorder	2.17e-05	0.000225	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—PIK3C2A—bipolar disorder	2.16e-05	0.000224	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—PIK3C2A—bipolar disorder	2.14e-05	0.000223	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—POMC—bipolar disorder	2.11e-05	0.00022	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—CLOCK—bipolar disorder	2.11e-05	0.000219	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—SNAP25—bipolar disorder	2.11e-05	0.000219	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—TPH2—bipolar disorder	2.05e-05	0.000213	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—CACNB2—bipolar disorder	2.05e-05	0.000213	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—TSHB—bipolar disorder	2.05e-05	0.000213	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—DPYD—bipolar disorder	2.02e-05	0.00021	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—SNAP25—bipolar disorder	1.94e-05	0.000201	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—SNAP25—bipolar disorder	1.92e-05	0.0002	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—CACNA1C—bipolar disorder	1.88e-05	0.000195	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—ADCY2—bipolar disorder	1.86e-05	0.000194	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—PIK3C2A—bipolar disorder	1.83e-05	0.00019	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—POMC—bipolar disorder	1.81e-05	0.000188	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—ADCY2—bipolar disorder	1.71e-05	0.000178	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—ADCY2—bipolar disorder	1.7e-05	0.000177	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—SNAP25—bipolar disorder	1.64e-05	0.000171	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—COMT—bipolar disorder	1.6e-05	0.000166	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—MAOA—bipolar disorder	1.58e-05	0.000165	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—COMT—bipolar disorder	1.47e-05	0.000153	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—MAOA—bipolar disorder	1.46e-05	0.000151	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—COMT—bipolar disorder	1.46e-05	0.000151	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—ADCY2—bipolar disorder	1.45e-05	0.000151	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—MAOA—bipolar disorder	1.45e-05	0.00015	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—MTHFR—bipolar disorder	1.29e-05	0.000134	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—COMT—bipolar disorder	1.24e-05	0.000129	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—MAOA—bipolar disorder	1.23e-05	0.000128	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—MTHFR—bipolar disorder	1.19e-05	0.000123	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—MTHFR—bipolar disorder	1.18e-05	0.000122	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—POMC—bipolar disorder	1.03e-05	0.000107	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—INS—bipolar disorder	1.03e-05	0.000107	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—MTHFR—bipolar disorder	1.01e-05	0.000104	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—POMC—bipolar disorder	9.49e-06	9.86e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—INS—bipolar disorder	9.44e-06	9.81e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—POMC—bipolar disorder	9.41e-06	9.78e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—INS—bipolar disorder	9.36e-06	9.72e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—POMC—bipolar disorder	8.04e-06	8.36e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—INS—bipolar disorder	8e-06	8.31e-05	CbGpPWpGaD
